2
Announcements
Trials
Browse
Landscape
Status
Completed
20
Recruiting
9
Unknown
3
Terminated
2
Not yet recruiting
2
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
1
Neoplasms
1
Embolism
1
Interventions
pembrolizumab
439
Carboplatin
322
Nivolumab
298
Cyclophosphamide
286
Specimen Handling
271
Magnetic Resonance Spectroscopy
259
Cisplatin
250
Paclitaxel
249
Radiotherapy
230
Dexamethasone
184
Biopsy
182
Gemcitabine
180
durvalumab
171
atezolizumab
152
Doxorubicin
141
Rituximab
138
Lenalidomide
136
Ipilimumab
134
Docetaxel
132
Bevacizumab
132
Radiation
121
Capecitabine
120
Oxaliplatin
116
Etoposide
116
Radiosurgery
113
Fluorouracil
112
Pemetrexed
109
fludarabine
106
venetoclax
102
Prednisone
97
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
apixaban
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled